[HTML][HTML] Papillary thyroid cancer prognosis: An evolving field

S Ulisse, E Baldini, A Lauro, D Pironi, D Tripodi, E Lori… - Cancers, 2021 - mdpi.com
… of the molecular pathogenesis underlying thyroid cancer progression, particularly for the
papillary thyroid cancer (PTC), which represents the most common thyroid malignancy. Putative …

BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications

M Xing - Endocrine reviews, 2007 - academic.oup.com
… The predilection of BRAF mutation for old and male patients may partially explain the
known association of old age and male gender with thyroid cancer progression and …

[HTML][HTML] CLDN10 is associated with papillary thyroid cancer progression

Y Zhou, J Xiang, A Bhandari, Y Guan, E Xia… - … of Cancer, 2018 - ncbi.nlm.nih.gov
The incidence of thyroid cancer is staying at a high level. Claudin family is a skelemin contacting
with the intercellular junction and can keep a dynamic balance between cells. Recently, …

Genome-wide appraisal of thyroid cancer progression

VB Wreesmann, RA Ghossein, SG Patel… - The American journal of …, 2002 - Elsevier
… variants of thyroid cancer to define genetic variables associated with progression. Overall,
a … was observed from well-differentiated papillary thyroid cancer to poorly differentiated and …

BRAFV600E and Microenvironment in Thyroid Cancer: A Functional Link to Drive Cancer Progression

C Nucera, J Lawler, S Parangi - Cancer research, 2011 - AACR
Papillary thyroid cancer (PTC) rates continue to increase in the United States and Europe,
and, although most patients do well, some recur and die of their disease. Patients with PTC …

[HTML][HTML] CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of β-catenin pathway

W Bi, J Huang, C Nie, B Liu, G He, J Han… - … & Clinical Cancer …, 2018 - Springer
… functions in diverse cancers. However, the role of circRNA_102171 in papillary thyroid cancer
(PTC… in PTC progression. And we also aimed to reveal its potential molecular mechanism. …

[HTML][HTML] KCNN4 is a diagnostic and prognostic biomarker that promotes papillary thyroid cancer progression

J Wen, B Lin, L Lin, Y Chen, O Wang - Aging (Albany NY), 2020 - ncbi.nlm.nih.gov
… The incidence of thyroid cancer remains high worldwide, and papillary thyroid cancer (PTC)
is the most common type. Potassium Calcium-Activated Channel Subfamily N Member 4 (…

p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer

DG McFadden, A Vernon… - Proceedings of the …, 2014 - National Acad Sciences
… mouse and used this strain to model progression of v-raf murine … papillary thyroid cancer to
anaplastic thyroid cancer (ATC). These murine tumors recapitulated the temporal progression

[HTML][HTML] CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis

Y Han, S Xu, K Cheng, C Diao… - Experimental and …, 2021 - spandidos-publications.com
… the critical role of CENPF in cancer progression. Future studies should be conducted to
determine whether CENPF affects the migration and invasion of gastric cancer cells in vitro and …

[HTML][HTML] CircRNA circTIAM1 promotes papillary thyroid cancer progression through the miR-646/HNRNPA1 signaling pathway

D Zhang, L Tao, N Xu, X Lu, J Wang, G He… - Cell Death …, 2022 - nature.com
… increase the risk of recurrence of thyroid cancer [22], and the … partly involved in tumor
progression as a circRNA originating … of circTIAM1 in papillary thyroid cancer progression, which …